GNH USA

Europe — EMA

Moxonidine Viatris

GNH USA supplies Moxonidine Viatris (Moxonidine), an imidazoline receptor agonist for hypertension. Request a quote for global supply.

Moxonidine

Request sourcing

1
Pack/s

What is Moxonidine?

Moxonidine, the active ingredient in Moxonidine Viatris, is an imidazoline receptor agonist presented as a tablet for oral use. It treats hypertension in adult patients.

GNH USA supplies Moxonidine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Moxonidine used for?

Moxonidine is an antihypertensive agent that acts on central imidazoline I1 receptors to lower blood pressure.

- Hypertension: reduces systolic and diastolic blood pressure in patients with essential hypertension.

What are the side effects of Moxonidine?

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dry mouth: sensation of oral dryness. - Fatigue: feeling of tiredness or reduced energy. - Dizziness: light‑headedness, especially when standing quickly. - Headache: mild to moderate head pain. - Nausea: upset stomach or urge to vomit. - Constipation: infrequent or difficult bowel movements.

Serious or Rare Side Effects: - Bradycardia: abnormally slow heart rate. - Severe hypotension: marked drop in blood pressure causing faintness. - Hepatic dysfunction: abnormal liver enzyme elevations. - Allergic reactions: rash, itching, or swelling. - Syncope: sudden loss of consciousness. - Cardiac arrhythmia: irregular heart rhythm.

What precautions apply to Moxonidine?

Before prescribing Moxonidine, clinicians should consider several safety aspects.

- Renal impairment: adjust therapy if severe kidney disease is present. - Hepatic disease: monitor liver function tests regularly. - Cardiovascular disease: use caution in patients with recent myocardial infarction or unstable angina. - Pregnancy: safety category unknown; avoid unless benefits outweigh risks. - Breastfeeding: unknown excretion in milk; consider alternatives. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

What does Moxonidine interact with?

Moxonidine can interact with other medicines that affect blood pressure or cardiac function.

Major Interactions (Avoid): - Beta‑blockers: may cause excessive bradycardia or hypotension. - Central alpha‑agonists (e.g., clonidine): additive depressor effects. - Strong CYP2D6 inhibitors: may increase plasma levels of moxonidine.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance antihypertensive effect, requiring dose adjustment. - ACE inhibitors or ARBs: combined use may lead to pronounced blood pressure reduction. - NSAIDs: can blunt antihypertensive response, necessitating closer monitoring.

Frequently asked questions

What is Moxonidine Viatris used for?+
Moxonidine Viatris is used to treat essential hypertension. It lowers elevated systolic and diastolic blood pressure by reducing sympathetic nervous system activity, helping to achieve target blood pressure levels in adult patients.
How does moxonidine work?+
Moxonidine acts as a selective agonist at central imidazoline I1 receptors. Activation of these receptors diminishes sympathetic outflow from the brain, which decreases peripheral vascular resistance and modestly reduces heart rate, ultimately lowering arterial blood pressure.
What is the usual dose of Moxonidine Viatris?+
The dosage of Moxonidine Viatris is determined by the prescribing clinician based on the patient’s clinical condition, response to therapy, and any comorbidities. The prescriber will set the appropriate dose and titration schedule.
Is Moxonidine safe during pregnancy or breastfeeding?+
The safety of Moxonidine in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and alternative therapies should be considered.
How do I order Moxonidine Viatris from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Moxonidine compare with other antihypertensive classes?+
Moxonidine differs from beta‑blockers, ACE inhibitors, and calcium‑channel blockers by targeting central imidazoline I1 receptors rather than peripheral receptors or enzymes. This mechanism offers a distinct profile of blood‑pressure reduction with a lower incidence of metabolic side effects, but individual response varies.
What are the storage requirements for Moxonidine Viatris?+
Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure they are out of reach of children.
How is Moxonidine Viatris administered?+
Moxonidine Viatris is taken orally, usually with or without food, as directed by the prescriber. The tablets should be swallowed whole with a glass of water and not chewed or crushed.
What are the most serious risks associated with Moxonidine?+
Serious risks include severe hypotension, bradycardia, hepatic dysfunction, and rare allergic reactions such as rash or swelling. Patients should be monitored for signs of these events, especially during dose initiation or adjustment.
Who should not use Moxonidine Viatris?+
Moxonidine is contraindicated in patients with known hypersensitivity to the drug or any of its excipients. Caution is advised in individuals with severe renal or hepatic impairment, uncontrolled heart failure, or those taking interacting medications that could cause excessive blood‑pressure lowering.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Moxonidine
Route
Oral Use
Manufacturer
Viatris Gx
Origin
EU

Related products

Cynt

Cynt

Moxonidine

Viatris Hrvatska D.O.O.
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Biomin, A.S.
EU